Share on StockTwits

Exactech (NASDAQ:EXAC) Director Albert H. Burstein unloaded 8,852 shares of the stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $23.73, for a total value of $210,057.96. Following the completion of the transaction, the director now directly owns 17,284 shares of the company’s stock, valued at approximately $410,149. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Exactech (NASDAQ:EXAC) traded down 0.80% during mid-day trading on Tuesday, hitting $23.60. 32,752 shares of the company’s stock traded hands. Exactech has a 52-week low of $18.34 and a 52-week high of $26.52. The stock has a 50-day moving average of $23.6 and a 200-day moving average of $23.3. The company has a market cap of $324.6 million and a P/E ratio of 20.51.

Exactech (NASDAQ:EXAC) last released its earnings data on Monday, July 28th. The company reported $0.30 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.30. The company had revenue of $63.92 million for the quarter, compared to the consensus estimate of $63.80 million. During the same quarter in the previous year, the company posted $0.27 earnings per share. The company’s revenue for the quarter was up 5.4% on a year-over-year basis. Analysts expect that Exactech will post $1.21 EPS for the current fiscal year.

Separately, analysts at Canaccord Genuity raised their price target on shares of Exactech from $31.00 to $32.00 in a research note on Wednesday, July 30th.

Exactech, Inc develops, manufactures and sells orthopedic implant devices, related surgical instruments and biological material and services to make patients more mobile.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.